首页> 外文OA文献 >Improving patient outcomes with regenerative medicine: How the Regenerative Medicine Manufacturing Society plans to move the needle forward in cell manufacturing, standards, 3D bioprinting, artificial intelligence‐enabled automation, education, and training

【2h】

Improving patient outcomes with regenerative medicine: How the Regenerative Medicine Manufacturing Society plans to move the needle forward in cell manufacturing, standards, 3D bioprinting, artificial intelligence‐enabled automation, education, and training

机译：通过再生医学改善患者结果：再生医学制造业社会如何计划将针头移动到细胞制造，标准，3D生物印刷，支持人工智能的自动化，教育和培训中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Joshua Hunsberger; Carl Simon; Claudia Zylberberg; Preveen Ramamoorthy; Thomas Tubon; Ram Bedi; Kurt Gielen; Caitlin Hansen; Lynn Fischer; Jed Johnson; Priya Baraniak; Behzad Mahdavi; Taciana Pereira; Michael Hadjisavas; Shannon Eaker; Cameron Miller;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Improving patient outcomes with regenerative medicine: How the Regenerative Medicine Manufacturing Society plans to move the needle forward in cell manufacturing, standards, 3D bioprinting, artificial intelligence‐enabled automation, education, and training [J] . Joshua Hunsberger, Carl Simon, Claudia Zylberberg, Stem cells translational medicine. . 2020,第7期

机译：通过再生医学改善患者结果：再生医学制造业社会如何计划将针头移动到细胞制造，标准，3D生物印刷，支持人工智能的自动化，教育和培训中
2. Planning for Commercial Scale of Cell Therapy and Regenerative Medicine Products, Part 1:Achieving Manufacturability and Managing Cost of Goods [J] . Richard Grant BioProcess International . 2015,第Suppla2期

机译：规划细胞疗法和再生医学产品的商业规模，第1部分：实现可制造性和管理商品成本
3. 3D cell bioprinting for regenerative medicine research and therapies [J] . Khatiwala C., Law R., Shepherd B., Gene therapy and regulation: An international interdisciplinary journal . 2012,第1期

机译：用于再生医学研究和治疗的3D细胞生物打印
4. Improving patient outcomes with regenerative medicine: How the Regenerative Medicine Manufacturing Society plans to move the needle forward in cell manufacturing standards 3D bioprinting artificial intelligence‐enabled automation education and training [O] . Joshua Hunsberger, Carl Simon, Claudia Zylberberg, 2020

机译：再生医学改善患者结果：再生医学制造学会计划如何在细胞制造标准3D生物打印人工智能自动化教育和培训方面取得进步
5. A process engineering approach to the manufacture of cell-based regenerative medicines [O] . 2009

机译：一种制造细胞型再生药物的过程工程方法

Improving patient outcomes with regenerative medicine: How the Regenerative Medicine Manufacturing Society plans to move the needle forward in cell manufacturing, standards, 3D bioprinting, artificial intelligence‐enabled automation, education, and training

著录项

相似文献

相关主题

期刊订阅